{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:25:23Z","timestamp":1759335923041},"reference-count":122,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.transci.2010.01.008","type":"journal-article","created":{"date-parts":[[2010,2,6]],"date-time":"2010-02-06T09:36:07Z","timestamp":1265448967000},"page":"131-139","source":"Crossref","is-referenced-by-count":17,"title":["Human immunodeficiency and Hodgkin lymphoma"],"prefix":"10.1016","volume":"42","author":[{"given":"Gerhard","family":"Sissolak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagmar","family":"Sissolak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2010.01.008_bib1","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJM198112103052401","article-title":"Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency","volume":"305","author":"Gottlieb","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2010.01.008_bib2","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJM198305193082001","article-title":"Immunodeficiency in female sexual partners of men with the acquired immunodeficiency syndrome","volume":"308","author":"Harris","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2010.01.008_bib3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1470-2045(03)01142-2","article-title":"What can oncologists learn from HIV?","volume":"4","author":"Stebbing","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib4","first-page":"47","article-title":"Kaposi\u2019s sarcoma: a comparison of classical, endemic, and epidemic forms","volume":"11","author":"Ziegler","year":"1984","journal-title":"Semin Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib5","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(85)92216-0","article-title":"Increase in high-grade lymphomas in young men","volume":"1","author":"Boring","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2010.01.008_bib6","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1001\/jama.1985.03360140079029","article-title":"Retrovirus and malignant lymphoma in homosexual men","volume":"254","author":"Levine","year":"1985","journal-title":"JAMA"},{"key":"10.1016\/j.transci.2010.01.008_bib7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ctrv.2003.12.004","article-title":"The evidence-based treatment of AIDS-related non-Hodgkin\u2019s lymphoma","volume":"30","author":"Stebbing","year":"2004","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.transci.2010.01.008_bib8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3816\/CLM.2003.n.016","article-title":"Acquired immunodeficiency syndrome-related lymphoma in the era of highly active antiretroviral therapy","volume":"4","author":"Thirlwell","year":"2003","journal-title":"Clin Lymphoma"},{"key":"10.1016\/j.transci.2010.01.008_bib9","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ijc.1528","article-title":"Cancer incidence in women with or at risk for HIV","volume":"94","author":"Phelps","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.transci.2010.01.008_bib10","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(97)09028-4","article-title":"Spectrum of AIDS-associated malignant disorders","volume":"351","author":"Goedert","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2010.01.008_bib11","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1470-2045(03)00983-5","article-title":"Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS","volume":"4","author":"Dal Maso","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib12","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1200\/JCO.2003.09.107","article-title":"Multicenter study of human immunodeficiency virus-related germ cell tumors","volume":"21","author":"Powles","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib13","unstructured":"International Agency for Research on Cancer (IARC). Human immunodeficiency viruses and human T-cell lymphotropic viruses. Lyon: IARC, 1996:261-390. (monographs on the evaluation of carcinogenic risks to humans; Vol. 67)."},{"key":"10.1016\/j.transci.2010.01.008_bib14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ijc.23487","article-title":"Cancer risk in people infected with human immunodeficiency virus in the United States","volume":"123","author":"Engels","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.transci.2010.01.008_bib15","doi-asserted-by":"crossref","first-page":"5737","DOI":"10.1182\/blood-2009-02-204172","article-title":"Hodgkin lymphoma in the Swiss cohort study","volume":"113","author":"Clifford","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.transci.2010.01.008_bib16","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1182\/blood-2008-09-180315","article-title":"HIV-associated lymphomas and gamma-herpesviruses","volume":"113","author":"Carbone","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.transci.2010.01.008_bib17","unstructured":"UNAIDS. Report on the global AIDS epidemic. Geneva: UNAIDS; 2006."},{"key":"10.1016\/j.transci.2010.01.008_bib18","unstructured":"National HIV and syphilis sero-prevalence survey of women attending public health antenatal clinics in South Africa. Pretoria: Department of Health; 2005. <http:\/\/www.doh.gov.za\/docs\/reports\/2005\/hiv.pdf>."},{"key":"10.1016\/j.transci.2010.01.008_bib19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0093-7754(01)90092-2","article-title":"Acquired immunodeficiency syndrome-associated cancers in Sub-Saharan Africa","volume":"28","author":"Thomas","year":"2001","journal-title":"Semin Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib20","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1365-3156.2005.01491.x","article-title":"AIDS related Kaposi\u2019s sarcoma: epidemiological, diagnostic, treatment and control aspects in sub-Saharan Africa","volume":"10","author":"Sissolak","year":"2005","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.transci.2010.01.008_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.transci.2007.04.010","article-title":"AIDS defining lymphomas in the era of highly active antiretroviral therapy (HAART)\u2013an African perspective","volume":"37","author":"Sissolak","year":"2007","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2010.01.008_bib22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.7326\/0003-4819-117-4-309","article-title":"Increased incidence of Hodgkin disease in homosexual men with HIV infection","volume":"117","author":"Hessol","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transci.2010.01.008_bib23","first-page":"1680","article-title":"Current treatment and immunotherapy of Hodgkin\u2019s lymphoma","volume":"90","author":"Klimm","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.transci.2010.01.008_bib24","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/cncr.11459","article-title":"Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988\u20131998","volume":"98","author":"Glaser","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.transci.2010.01.008_bib25","series-title":"South African national HIV prevalence, HIV incidence, behaviour and communications survey","author":"Shisana","year":"2005"},{"key":"10.1016\/j.transci.2010.01.008_bib26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jnci\/dji072","article-title":"Cancer risk in the Swiss HIV cohort study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy","volume":"97","author":"Clifford","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.transci.2010.01.008_bib27","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.aids.0000238411.75324.59","article-title":"Trends in cancer risk among people with AIDS in the United States 1980\u20132002","volume":"20","author":"Engels","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.transci.2010.01.008_bib28","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1182\/blood-2006-05-024109","article-title":"Hodgkin lymphoma and immunodeficiency in persons with HIV\/AIDS","volume":"108","author":"Biggar","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.transci.2010.01.008_bib29","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/00002030-200205240-00009","article-title":"Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis","volume":"16","author":"Grulich","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.transci.2010.01.008_bib30","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/cncr.21334","article-title":"Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals","volume":"104","author":"Burgi","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.transci.2010.01.008_bib31","unstructured":"International Agency for Research on Cancer (IARC). Epstein-Barr virus and Kaposi\u2019s sarcoma herpesvirus\/human herpesvirus 8. Lyon: IARC; 1997 [Monographs on the evaluation of carcinogenic risks to humans; Vol. 70]."},{"key":"10.1016\/j.transci.2010.01.008_bib32","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0959-8049(01)00105-8","article-title":"Pathogenetic and histogenetic features of HIV-associated Hodgkin\u2019s disease","volume":"37","author":"Dolcetti","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.transci.2010.01.008_bib33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ijc.2910540110","article-title":"High incidence of monoclonal EBV episomes in Hodgkin\u2019s disease and anaplastic large-cell KI-1-positive lymphomas in HIV-1-positive patients","volume":"54","author":"Boiocchi","year":"1993","journal-title":"Int J Cancer"},{"key":"10.1016\/j.transci.2010.01.008_bib34","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0889-8588(03)00046-7","article-title":"Hodgkin\u2019s disease in HIV","volume":"17","author":"Spina","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.transci.2010.01.008_bib35","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/(SICI)1097-0215(19970207)70:4<375::AID-IJC1>3.0.CO;2-T","article-title":"Epstein-Barr virus-associated Hodgkin\u2019s disease: epidemiologic characteristics in international data","volume":"70","author":"Glaser","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.transci.2010.01.008_bib36","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00126334-200212150-00012","article-title":"Prevalence of hepatitis C virus infection and risk for hepatocellular carcinoma and non-Hodgkin lymphoma in AIDS","volume":"31","author":"Engels","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.transci.2010.01.008_bib37","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/jnci\/92.18.1500","article-title":"Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome","volume":"92","author":"Frisch","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.transci.2010.01.008_bib38","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0959-8049(01)00122-8","article-title":"Clinical aspects and management of Hodgkin\u2019s disease and other tumours in HIV-infected individuals","volume":"37","author":"Vaccher","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.transci.2010.01.008_bib39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/oxfordjournals.jncimonographs.a024171","article-title":"Hodgkin\u2019s disease in the setting of human immunodeficiency virus infection","volume":"23","author":"Levine","year":"1998","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.transci.2010.01.008_bib40","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/oxfordjournals.annonc.a058617","article-title":"Hodgkin\u2019s disease during HIV1 infection: the French registry experience. French registry of HIV-associated tumors","volume":"4","author":"Andrieu","year":"1993","journal-title":"Ann Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/ajot.2002.28778","article-title":"Hodgkin\u2019s disease of the head and neck in human immunodeficiency virus-infected patients","volume":"23","author":"Poluri","year":"2002","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.transci.2010.01.008_bib42","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMe078173","article-title":"Hodgkin\u2019s disease\u2013from pathology specimen to cure","volume":"357","author":"Diehl","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2010.01.008_bib43","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood-2005-06-2252","article-title":"FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma","volume":"107","author":"Hutchings","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.transci.2010.01.008_bib44","first-page":"475","article-title":"The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin\u2019s disease","volume":"91","author":"Gallamini","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.transci.2010.01.008_bib45","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1200\/JCO.2007.11.6525","article-title":"Early Interim 2-[18F]Fluoro-2-deoxy-d-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin\u2019s lymphoma: a report from a joint Italian\u2013Danish study","volume":"25","author":"Gallamini","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib46","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1200\/JCO.2007.11.9867","article-title":"Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin\u2019s disease","volume":"25","author":"Advani","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib47","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1200\/JCO.2004.12.170","article-title":"ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin\u2019s disease: long-term results","volume":"22","author":"Bonadonna","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib48","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1200\/JCO.2006.07.0482","article-title":"Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin\u2019s lymphoma: final results of the GHSG HD7 trial","volume":"25","author":"Engert","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib49","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.1200\/JCO.2005.05.016","article-title":"State-of-the-art therapeutics: Hodgkin\u2019s lymphoma","volume":"23","author":"Connors","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib50","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1200\/JCO.2003.12.086","article-title":"Randomized comparison of ABVD and MOPP\/ABV hybrid for the treatment of advanced Hodgkin\u2019s disease: report of an intergroup trial","volume":"21","author":"Duggan","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib51","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM199211193272102","article-title":"Chemotherapy of advanced Hodgkin\u2019s disease with MOPP, ABVD, or MOPP alternating with ABVD","volume":"327","author":"Canellos","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2010.01.008_bib52","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1200\/JCO.2005.09.085","article-title":"Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin\u2019s lymphoma: national cancer institute of Canada clinical trials group and the eastern cooperative oncology group","volume":"23","author":"Meyer","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib53","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2141.2007.06598.x","article-title":"G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis","volume":"137","author":"Evens","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2010.01.008_bib54","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1200\/JCO.2005.02.7243","article-title":"Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin\u2019s lymphoma","volume":"23","author":"Martin","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib55","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1200\/JCO.20.3.630","article-title":"Stanford V and radiotherapy for locally extensive and advanced Hodgkin\u2019s disease: mature results of a prospective clinical trial","volume":"20","author":"Horning","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib56","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1056\/NEJMoa022473","article-title":"Standard and increased-dose BEACOPP chemotherapy compared with COPP\u2013ABVD for advanced Hodgkin\u2019s disease","volume":"348","author":"Diehl","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2010.01.008_bib57","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","article-title":"A prognostic score for advanced Hodgkin\u2019s disease","volume":"339","author":"Hasenclever","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2010.01.008_bib58","doi-asserted-by":"crossref","unstructured":"Wedgwood AR, Fanale MA, Fayad LE, McLaughlin P, Hagemeister FB, Pro B, et al. Rituximab+ABVD improves event-free survival (EFS) in patients with classical Hodgkin lymphoma in all international prognostic score (IPS) groups and in patients who have PET positive disease after 2\u20133 cycles of therapy. Blood 2007;110:71a [abstract 215].","DOI":"10.1182\/blood.V110.11.215.215"},{"key":"10.1016\/j.transci.2010.01.008_bib59","doi-asserted-by":"crossref","unstructured":"Jones RJ, Lin L, Gocke C, Hensley K, Siedner M, Barber JP, et al. Clonotypic B cells circulate in Hodgkin\u2019s lymphoma (HL). Blood 2006;108:143a [Abstract 470].","DOI":"10.1182\/blood.V108.11.470.470"},{"key":"10.1016\/j.transci.2010.01.008_bib60","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1200\/JCO.1992.10.2.210","article-title":"Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin\u2019s disease after combination chemotherapy: the low probability for cure","volume":"10","author":"Longo","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib61","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1200\/JCO.1997.15.2.528","article-title":"Outcome of patients with Hodgkin\u2019s disease failing after primary MOPP-ABVD","volume":"15","author":"Bonfante","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib62","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1200\/JCO.1990.8.4.623","article-title":"Prognostic factors for patients relapsing after radiotherapy for early-stage Hodgkin\u2019s disease","volume":"8","author":"Roach","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib63","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1200\/JCO.1987.5.4.544","article-title":"Wide-field radiation therapy alone or with chemotherapy for Hodgkin\u2019s disease in relapse from combination chemotherapy","volume":"5","author":"Mauch","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib64","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.1987.5.4.550","article-title":"Radiotherapy with curative intent: an option in selected patients relapsing after chemotherapy for advanced Hodgkin\u2019s disease","volume":"5","author":"Roach","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib65","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood.V77.10.2292.2292","article-title":"Outcome of treatment of first relapse of Hodgkin\u2019s disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1988","volume":"77","author":"Lohri","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.transci.2010.01.008_bib66","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1182\/blood.V89.3.814","article-title":"Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin\u2019s disease","volume":"89","author":"Yuen","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.transci.2010.01.008_bib67","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/10245330500276592","article-title":"A phase II study of thalidomide and vinblastine for palliative patients with Hodgkin\u2019s lymphoma","volume":"11","author":"Kuruvilla","year":"2006","journal-title":"Hematology"},{"key":"10.1016\/j.transci.2010.01.008_bib68","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1182\/blood-2007-03-078725","article-title":"Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG)","volume":"111","author":"Schulz","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.transci.2010.01.008_bib69","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0140-6736(93)92411-L","article-title":"Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin\u2019s disease: results of a BNLI randomised trial","volume":"341","author":"Linch","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2010.01.008_bib70","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/annonc\/mdi119","article-title":"Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin\u2019s lymphoma autografted after a first relapse","volume":"16","author":"Sureda","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib71","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2141.2003.04828.x","article-title":"Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin\u2019s disease","volume":"124","author":"Moskowitz","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2010.01.008_bib72","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/annonc\/mdm090","article-title":"Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin\u2019s lymphoma: CALGB 59804","volume":"18","author":"Bartlett","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib73","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/cncr.21587","volume":"106","author":"Kuruvilla","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.transci.2010.01.008_bib74","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1200\/JCO.1994.12.2.279","volume":"12","author":"Somers","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib75","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1200\/JCO.1998.16.3.818","article-title":"Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin\u2019s disease. International database on Hodgkin\u2019s disease overview study group","volume":"16","author":"Loeffler","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib76","first-page":"2246","article-title":"Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin\u2019s disease: results of the Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte H89 trial","volume":"95","author":"Ferm\u00e9","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.transci.2010.01.008_bib77","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1200\/JCO.2000.18.5.972","article-title":"Assessment of the Stanford V regimen and consolidative radiotherapy for bulky and advanced Hodgkin\u2019s disease: eastern cooperative oncology group pilot study E1492","volume":"18","author":"Horning","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib78","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1053-4296(96)80018-X","article-title":"Long-term complications of treatment and causes of mortality after Hodgkin\u2019s disease","volume":"6","author":"Hancock","year":"1996","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib79","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1200\/JCO.2000.18.12.2435","article-title":"Second cancers among long-term survivors of Hodgkin\u2019s disease diagnosed in childhood and adolescence","volume":"18","author":"Metayer","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib80","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1200\/JCO.2000.18.3.487","article-title":"Long-term risk of second malignancy in survivors of Hodgkin\u2019s disease treated during adolescence or young adulthood","volume":"18","author":"van Leeuwen","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib81","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1200\/JCO.2002.09.038","article-title":"Second malignant neoplasms among long-term survivors of Hodgkin\u2019s disease: a population-based evaluation over 25 years","volume":"20","author":"Dores","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib82","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2003.07.131","article-title":"Long-term cause-specific mortality of patients treated for Hodgkin\u2019s disease","volume":"21","author":"Aleman","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib83","unstructured":"van Leeuwen FE, Swerdlow AJ, Valagussa P, Tucker MA. Second cancers after treatment of Hodgkin\u2019s disease. In: Mauch PM, Armitage JO, Diehl V, Hoppe RT, Weiss LM, editors. Hodgkin\u2019s disease. Philadelphia: Lippincott Williams and Wilkins; 1999: 607\u201332."},{"key":"10.1016\/j.transci.2010.01.008_bib84","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJM199001043220102","article-title":"Leukemia following Hodgkin\u2019s disease","volume":"322","author":"Kaldor","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2010.01.008_bib85","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/bjc.1990.287","article-title":"Immunity in Hodgkin\u2019s disease: status after 10 years\u2019 remission","volume":"62","author":"Bruce","year":"1990","journal-title":"Br J Cancer"},{"key":"10.1016\/j.transci.2010.01.008_bib86","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/1097-0142(197711)40:5<2071::AID-CNCR2820400513>3.0.CO;2-V","article-title":"The long term effects of radiation of T and B lymphocytes in the peripheral blood after regional irradiation","volume":"40","author":"Hoppe","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.transci.2010.01.008_bib87","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/jnci\/87.20.1530","article-title":"Roles of radiotherapy and smoking in lung cancer following Hodgkin\u2019s disease","volume":"87","author":"van Leeuwen","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.transci.2010.01.008_bib88","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1515\/JPM.2003.070","article-title":"MRI during pregnancy","volume":"31","author":"Kawabata","year":"2003","journal-title":"J Perinat Med"},{"key":"10.1016\/j.transci.2010.01.008_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmri.20608","article-title":"Obstetric MRI","volume":"24","author":"Levine","year":"2006","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.transci.2010.01.008_bib90","first-page":"1238","article-title":"Pattern of uptake and excretion of 18F-FDG in the lactating breast","volume":"42","author":"Hicks","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1016\/j.transci.2010.01.008_bib91","first-page":"1522","article-title":"Maternal-fetal in vivo imaging: a combined PET and MRI study","volume":"44","author":"Benveniste","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1016\/j.transci.2010.01.008_bib92","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1586\/14737140.4.5.889","article-title":"Impact and treatment of cancer during pregnancy","volume":"4","author":"Weisz","year":"2004","journal-title":"Exper Rev Anticancer Ther"},{"key":"10.1016\/j.transci.2010.01.008_bib93","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1470-2045(04)01466-4","article-title":"Use of chemotherapy during human pregnancy","volume":"5","author":"Cardonick","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib94","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1001\/archinte.1988.00380090118027","article-title":"Management of cancer during pregnancy","volume":"148","author":"Doll","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.transci.2010.01.008_bib95","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1001\/jama.1993.03500030015003","article-title":"National registry seeks scarce data on pregnancy outcomes during chemotherapy","volume":"269","author":"Randall","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.transci.2010.01.008_bib96","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3816\/CLM.2001.n.023","article-title":"Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero","volume":"2","author":"Aviles","year":"2001","journal-title":"Clin Lymphoma"},{"key":"10.1016\/j.transci.2010.01.008_bib97","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/humupd\/7.4.384","article-title":"Cancer in pregnancy: maternal and fetal implications","volume":"7","author":"Weisz","year":"2001","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.transci.2010.01.008_bib98","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/bjc.1992.21","article-title":"Maternal and foetal outcome following Hodgkin\u2019s disease in pregnancy","volume":"65","author":"Lishner","year":"1992","journal-title":"Br J Cancer"},{"key":"10.1016\/j.transci.2010.01.008_bib99","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/archinte.1992.00400150093017","article-title":"Fetal outcome after in utero exposure to cancer chemotherapy","volume":"152","author":"Zemlickis","year":"1992","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.transci.2010.01.008_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/ctrv.2000.0193","article-title":"Pregnancy and radiation","volume":"27","author":"Fenig","year":"2001","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.transci.2010.01.008_bib101","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S1470-2045(05)70169-8","article-title":"Radiotherapy during pregnancy: fact and fiction","volume":"6","author":"Kal","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib102","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000052914","article-title":"Erythropoietin in the treatment of iron deficiency anemia during pregnancy","volume":"51","author":"Sifakis","year":"2001","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.transci.2010.01.008_bib103","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1634\/theoncologist.10-6-412","article-title":"AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy","volume":"10","author":"Cheung","year":"2005","journal-title":"Oncologist"},{"key":"10.1016\/j.transci.2010.01.008_bib104","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/00042560-200008150-00009","volume":"24","author":"Levine","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.transci.2010.01.008_bib105","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3816\/CLM.2007.n.014","article-title":"Hodgkin lymphoma among patients infected with HIV in post-HAART era","volume":"7","author":"Tanaka","year":"2007","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.transci.2010.01.008_bib106","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2141.2004.04934.x","article-title":"Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin\u2019s disease","volume":"125","author":"Hoffmann","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2010.01.008_bib107","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00002030-200301030-00011","article-title":"Improved survival in HIV-related Hodgkin\u2019s lymphoma since the introduction of highly active antiretroviral therapy","volume":"17","author":"Gerard","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.transci.2010.01.008_bib108","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3324\/haematol.10479","article-title":"Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin\u2019s lymphoma. GESIDA group and GELCAB group","volume":"92","author":"Xicoy","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.transci.2010.01.008_bib109","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/annonc\/mdf239","article-title":"Hodgkin\u2019s disease in HIV-infected patients: report of eight cases usefully treated with doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) plus granulocyte colony-stimulating factor","volume":"13","author":"Gastaldi","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib110","first-page":"623","article-title":"Pathogenesis of AIDS-related lymphomas","volume":"152","author":"Gaidano","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.transci.2010.01.008_bib111","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/annonc\/mdg408","article-title":"BEACOPP therapeutic regimen for patients with Hodgkin\u2019s disease and HIV infection","volume":"14","author":"Hartmann","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib112","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1182\/blood-2002-03-0989","article-title":"Stanford V and concomitant HAART in 59 patients with Hodgkin\u2019s disease and HIV infection","volume":"100","author":"Spina","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.transci.2010.01.008_bib113","doi-asserted-by":"crossref","first-page":"100a","DOI":"10.1182\/blood.V106.11.329.329","article-title":"VEBEP regimen and highly active antiretroviral therapy (HAART) in patients with HD and HIV Infection (HD-HIV)","volume":"106","author":"Spina","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.transci.2010.01.008_bib114","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/annonc\/mdg152","article-title":"High international prognostic score predicts a worse outcome for patients with Hodgkin\u2019s disease and HIV infection: results of a prospective study with Stanford V regimen","volume":"14","author":"Spina","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib115","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","article-title":"A prognostic score for advanced Hodgkin\u2019s disease","volume":"339","author":"Hasenclever","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2010.01.008_bib116","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1023\/A:1008338915945","article-title":"Hodgkin\u2019s disease in 35 patients with HIV infection: an experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSG","volume":"10","author":"Errante","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1016\/j.transci.2010.01.008_bib117","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/1097-0142(19940115)73:2<437::AID-CNCR2820730232>3.0.CO;2-2","article-title":"Combined antineoplastic and anti-retroviral therapy for patients with Hodgkin\u2019s disease and human immunodeficiency virus infection. A prospective study of 17 patients. The Italian cooperative group on AIDS and tumors (GICAT)","volume":"73","author":"Errante","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.transci.2010.01.008_bib118","unstructured":"Sissolak G, Andrews S, Abayomi A, Jacobs P. Haematopoietic and cardiovascular complications in patients infected with the human immunodeficiency virus Resources Cardiovasc Sci 2009; 17p."},{"key":"10.1016\/j.transci.2010.01.008_bib119","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.296.7.827","article-title":"Treatment for adult HIV infection: 2006 recommendations of the International AIDS society-USA panel","volume":"296","author":"Hammer","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.transci.2010.01.008_bib120","doi-asserted-by":"crossref","first-page":"946","DOI":"10.7326\/0003-4819-126-12-199706150-00003","article-title":"Plasma viral load and CD4+lymphocytes as prognostic markers of HIV-1 infection","volume":"126","author":"Mellors","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transci.2010.01.008_bib121","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11904-007-0008-7","article-title":"Should antiretroviral therapy be started earlier?","volume":"4","author":"Gallant","year":"2007","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.transci.2010.01.008_bib122","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00126334-200304150-00010","article-title":"Immune deficiency and risk for malignancy among persons with AIDS","volume":"32","author":"Mbulaiteye","year":"2003","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050210000091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050210000091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T18:35:38Z","timestamp":1590604538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050210000091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":122,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S1473050210000091"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2010.01.008","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}